Edition:
India

Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS)

600196.SS on Shanghai Stock Exchange

43.90CNY
22 Jun 2018
Change (% chg)

¥1.10 (+2.57%)
Prev Close
¥42.80
Open
¥42.60
Day's High
¥44.03
Day's Low
¥42.03
Volume
17,904,643
Avg. Vol
23,905,090
52-wk High
¥48.28
52-wk Low
¥28.00

Latest Key Developments (Source: Significant Developments)

Shanghai Fosun Pharma's Unit Agrees To Buy 28 Pct Stake In Medical Equipment Firm For 406 Mln Yuan
Wednesday, 20 Jun 2018 

June 20 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK::SAYS UNIT AGREES TO BUY 28 PERCENT STAKE IN MEDICAL EQUIPMENT FIRM FOR 406 MILLION YUAN ($62.73 million).  Full Article

Shanghai Fosun Pharmaceutical Group Enters Into JV Contract
Monday, 14 May 2018 

May 14 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>::CO, WANBANG CLOUD HEALTH, SFHIH AND HAITUN INTERNATIONAL ENTERED INTO JV CONTRACT.JV CONTRACT IN RELATION TO ESTABLISHMENT OF JV COMPANY WITH A REGISTERED CAPITAL OF RMB18 MILLION.CO PROPOSED TO MAKE CASH CONTRIBUTION OF RMB4.5 MILLION, REPRESENTING 25% OF STAKE IN JV CO.  Full Article

Shanghai Fosun Pharmaceutical Group unit receives GMP certificate
Wednesday, 9 May 2018 

May 9 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Says its pharmaceutical institute unit received goods manufacture practice (GMP) certificate from Chongqing Food and Drug Administration .Certificate issued to iron sucrose manufactured by the unit and the valid period is until April 19, 2023 .  Full Article

Shanghai Fosun Pharmaceutical Group to pay cash dividend of 3.8 yuan (pre-tax) for every 10 shares
Tuesday, 27 Mar 2018 

March 27 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Says it plans to pay a cash dividend of 3.8 yuan (pre-tax) for every 10 shares as the dividend payment plan for 2017.  Full Article

Shanghai Fosun Pharmaceutical's 2017 Net Profit Up, To Invest Up To 1 Bln Yuan In Project
Monday, 26 Mar 2018 

March 26 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK::SAYS 2017 NET PROFIT UP 11.4 PERCENT Y/Y.SAYS IT PLANS TO INVEST UP TO 1.03 BILLION YUAN IN MEDICINE PRODUCTION, INDUSTRIAL CENTRE PROJECT.  Full Article

Shanghai Fosun Pharmaceutical Group units receive approval for drug clinical trials
Wednesday, 24 Jan 2018 

Jan 24 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Says two pharmaceutical units received drug clinical trials approval for capsule FCN-437c and crude drug, which will be mainly used for treatment of solid tumor .  Full Article

Shanghai Fosun Pharmaceutical Group units receive approval for drug clinical trials
Wednesday, 17 Jan 2018 

Jan 17 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Says two Shanghai-based pharmaceutical units received drug clinical trials approval for injection FN-1501, which is mainly used for treatment of leukemia.  Full Article

Shanghai Fosun Plans U.S. JV, To Boost Capital Of Shanghai Biotech Firm
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK::SAYS UNIT PLANS TO INVEST $25.5 MILLION TO SET UP JV IN THE U.S..SAYS IT PLANS TO BOOST CAPITAL OF SHANGHAI BIOTECH FIRM BY 102 MILLION YUAN ($15.68 million).  Full Article

Shanghai Fosun Pharmaceutical Group unit receives GMP certificate
Monday, 1 Jan 2018 

Jan 1 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS> ::* Says its Jiangsu unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration .* Certificate issued tablets and hard capsules manufactured by the unit and the valid period is until Dec. 25, 2022.  Full Article

Shanghai Fosun Pharmaceutical Group signs project investment framework agreement
Friday, 29 Dec 2017 

Dec 29(Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS> ::Says it signed a project investment framework agreement with Xuzhou-based economic and technological development zone management committee.  Full Article